Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in Tumor

PURPOSE: The paradigm shift in cancer treatment from cytotoxic drugs to tumor targeted therapies poses new challenges, including optimization of dose and schedule based on a biologically effective dose, rather than the historical maximum tolerated dose. Optimal dosing is currently determined using c...

Descripción completa

Detalles Bibliográficos
Autores principales: Spector, Neil L., Robertson, Faith C., Bacus, Sarah, Blackwell, Kimberly, Smith, Deborah A., Glenn, Kelli, Cartee, Leanne, Harris, Jennifer, Kimbrough, Carie L., Gittelman, Mark, Avisar, Eli, Beitsch, Peter, Koch, Kevin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646457/
https://www.ncbi.nlm.nih.gov/pubmed/26571496
http://dx.doi.org/10.1371/journal.pone.0142845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646457/
https://www.ncbi.nlm.nih.gov/pubmed/26571496
http://dx.doi.org/10.1371/journal.pone.0142845

Ejemplares similares